期刊文献+

流式细胞免疫分型联合PCR检测抗原受体基因重排在淋巴增殖性疾病诊断与鉴别诊断中的应用 被引量:1

Application of flow cytometric immunophenotyping combined with polymerase chain reaction examination for antigen receptor gene rearrangement in the diagnosis of lymphoproliferative diseases
下载PDF
导出
摘要 背景与目的:淋巴增殖性疾病是一组病理形态、免疫表型、临床特征高度异质性的疾病。本文旨在评价流式细胞免疫分型联合聚合酶链反应(PCR)检测抗原受体基因重排在淋巴增殖性疾病诊断中的应用价值。方法:分离79例拟诊淋巴增殖性疾病患者的新鲜病理标本(淋巴结、脾脏、胃活检组织和肝穿组织),流式细胞术分析细胞的免疫表型特征;同时采用BIOMED-2多重PCR分析组织的抗原受体基因重排状况及其克隆来源;并与病理诊断及免疫组织化学结果进行比对。结果:患者最终确诊为非霍奇金淋巴瘤(non-Hodgkin'slymphoma,NHL)37例(46.8%),霍奇金淋巴瘤(Hodgkin's lymphoma,HL)3例(3.8%),淋巴组织良性病变34例(43.0%),恶性肿瘤淋巴结转移4例(5.1%)。在19例B-NHL确诊患者中,流式免疫分型和抗原受体基因重排诊断符合率均为94.7%(18例):18例T-NHL确诊患者中,流式免疫分型和抗原受体基因重排诊断符合率分别为72.2%(13例)和50%(9例);在34例淋巴组织良性病变的患者中,流式细胞免疫分型虽未见单克隆幼稚细胞,但有7例(19.4%)抗原受体基因重排呈单克隆性;在3例HL确诊患者中,流式免疫分型未能检测出来,抗原受体基因重排均为多克隆性;4例恶性肿瘤转移患者中(3例转移浸润淋巴结,1例转移浸润肝脏),流式细胞免疫分型均检测到大量异常幼稚细胞,其中3例无特殊抗体标记,另外1例表达幼稚髓系标记;抗原受体基因重排均为多克隆性。结论:应用流式细胞免疫分型联合抗原受体基因重排分析,对于淋巴组织良、恶性增殖的鉴别和不同类型恶性淋巴瘤的诊断,具有很好的辅助价值。 Background and purpose:Lymphoproliferative disease is a disease of highly heterogeneous pathology,immunophenotype and clinical features.The study was aimed to estimate the diagnostic value of flow cytometric immunophenotyping combined with polymerase chain reaction for detection of antigen receptor gene rearrangements for lymphoproliferative diseases.Methods:Fresh samples(lymph nodes,spleen,gastric and hepatic tissue obtained by biopsy or operation)of 79 cases suspected as lymphoproliferative diseases were isolated and their immunophenotypes were examined by flow cytometry.Meanwhile,gene rearrangement and clonal origin of antigen receptors of these samples were analyzed by BIOMED-2 multiplex polymerase chain reaction.And the outcome was compared with pathological diagnosis and immunohistochemical results.Results:Thirty-seven of the 79 cases (46.8%)were confirmed as non-Hodgkin's lymphoma(NHL),3 cases(3.8%)Hodgkin's lymphoma(HL),34 cases (43.0%)benign lymphoid tissues,while 4 cases(5.1%)were finally diagnosed as metastatic malignant tumor.The accurate rates of flow cytometric immunophenotyping and antigen receptor gene rearrangement diagnosis in 19 cases confirmed as B-NHL were both 94.7%(18 cases).Among 18 cases diagnosed as T-NHL,the conformity rate of the former was 72.2%(13 cases)and the latter was 50%(9 cases).In the 34 cases proved to be benign lymphoid tissue, flow cytometric immunophenotyping showed no monoclonal naive cells.However,monoclonal rearrangements were found in 7 samples(16.7%).Polyclonal rearrangements were found in the 3 cases of HL which failed to be confirmed by the flow cytometric immunophenotyping.And a large number of immature cells were detected by flow cytometric immunophenotyping in the 4 metastatic malignant tumor cases(3 with lymph node invasion,1 with liver metastasis), of which no specific antibody was found in 3 cases,while immature myeloid marker was detected in 1 case.And polyclonal rearrangements were showed in all of these 4 samples.Conclusion:Combined use of flow cytometric immunophenotype and antigen receptor gene rearrangement analysis is good auxiliary method for differential diagnosis of lymphoproliferative diseases and identification of different types of malignant lymphoma,particularly in atypical cases.
出处 《中国癌症杂志》 CAS CSCD 北大核心 2011年第10期741-747,共7页 China Oncology
基金 国家自然科学基金资助项目(No:30800402)
关键词 淋巴增殖性疾病 流式免疫分型 聚合酶链反应 诊断 Lymphoproliferative disease Flow cytometric immunophenotyping Polymerase chain reaction Diagnosis
  • 相关文献

参考文献9

  • 1KATZ R L.Modern approach to lymphoma diagnosis by fine- needle aspiration:restoring respect to a valuable procedure [J].Cancer,2005,105:429-431.
  • 2黄亮,熊婕,耿哲,柯昌庶,刘艳玲,黄梅,李登举,肖毅,汤屹,孟凡凯,邓金牛,孙汉英,刘文励,周剑峰.BIOMED-2多重聚合酶链反应检测抗原受体基因重排在淋巴增殖性疾病诊断中的应用[J].中华血液学杂志,2009,30(4):251-254. 被引量:4
  • 3CHIZUKA A,KANDA Y,NANNYA Y,et al.The diagnostic value of kappa/lambda ratios determined by flow cytometric analysis of biopsy specimens in B-cell lymphoma[J].Clin Lab Haematol,2002,24(1):33-36.
  • 4JENNINGS C D,FOON K A.Recent advances in flow cytometry:application to the diagnosis of hematologic malignancy [J].Blood,1997,90:2863-2892.
  • 5CAREY J L.Immunotyping of chronic lymphoid leukemias and related non-Hodgkin's leukemias.In:Steward CC, Nicholson JKA.Immunophentyping[M].New York: Wiley-Liss press,2000,181-213.
  • 6SEITZ V,HUMMEL M,MARAFIOTI T,et al.Detection of clonal T-cell receptor gamma-chain gene rearrangements in Reed-Sternberg cells of classic Hodgkin disease[J]. Blood,2000,95:3020-3024.
  • 7KANZLER H,KUPPERS R,HANSMANN M L,et al.Hodgkin and Reed-Sternberg cells in Hodgkin'S disease represent the outgrowth of a dominant tumor clone derived from(crippled) germinal center B cells[J].J Exp Med,1996,184:1495- 1505.
  • 8MARAFIOTI T,HUMMEL M,FOSS H D,et al.Hodgkin and reed-sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription [J].Blood,2000,95:1443- 1450.
  • 9VAN D J J,LANGERAK A W,BRUGGEMANN M,et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations:report of the BIOMED-2 concerted action BMH4-CT98-3936[J]. Leukemia,2003,17:2257-2317.

二级参考文献9

  • 1van Dongen J J, Langerak AW, Brtiggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-C198-3936. Leukemia, 2003, 17:2257-2317.
  • 2Jaffe ES, Stein H, Vardiman JW. World Health Organization classification of tumours. Lyon: IARC Press, 2001.
  • 3Rezuke WN, Abernathy EC, Tsongalis GJ. Molecular diagnosis of B- and T-cell lymphomas: fundamental principles and clinical applications. Clin Chem, 1997, 43:1814-1823.
  • 4Arber DA. Molecular diagnostic approach to non-Hodgkin' s lymphoma. J Mol Diagn, 2000, 2:178-190.
  • 5Aljurf M, Ezzat A, O Musa M. Emerging role of gammadeha T- cells in health and diease. Blood Rev, 2002, 16:203-206.
  • 6Kuppers R, Klein U, Hansmann ML, et al. Cellular origin of hu- man B-cell lymphomas. N Engl J Med, 1999, 341:1520-1529.
  • 7Hodges E, Krishna MT, Pickard C, et al. Diagnostic role of tests for T cell receptor (TCR) genes. J Clin Pathol, 2003, 56 : 1-11.
  • 8Waterston A, Bower M. Fifty years of multicentric Castleman' s disease. Acta Oncologica, 2004, 43:698-704.
  • 9Sandberg Y, van Gastel-Mol EJ, Verhaaf B, et al. BIOMED-2 muhiplex immunoglobulin/T-cell receptor polymerase chain reaction protocols can reliably replace southern blot analysis in routine clonality diagnostics. J Mol Diag, 2005, 7:495-503.

共引文献3

同被引文献25

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部